SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ciphergen Biosystems(CIPH):

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tuck1/24/2007 1:22:57 PM
   of 510
 
Dr. Merryweather, EVP of sales and marketing, got tired of twiddling his thumbs after the sale of the hardware business:

>>11-Jan-2007

Change in Directors or Principal Officers, Financial Statements and Exhi

Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers.

(b) On January 5, 2007, Ciphergen Biosystems, Inc. (the "Company") received the resignation of James P. Merryweather, the Executive Vice President, Sales & Marketing of the Company whose role principally supported the Company's tools business. Concurrent with Dr. Merryweather's resignation, the Company entered into a consulting agreement (the "Consulting Agreement") with him whereby Dr. Merryweather will continue to provide consulting services to the Company as requested for up to six months following his resignation, agree not to compete with the Company or solicit the services of the Company's employees, and provides a general release of claims in favor of the Company. In consideration, Dr. Merryweather will continue to receive compensation at his current base rate of pay during the term of the consulting period.<<

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext